JBF Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-350
Closed -$1K 115
2020
Q3
$1K Buy
+350
New +$1.66K ﹤0.01% 162
2018
Q4
Sell
-350
Closed -$6K 126
2018
Q3
$6K Buy
+350
New +$5.21K ﹤0.01% 151
2018
Q1
Sell
-350
Closed -$4K 92
2017
Q4
$4K Buy
+350
New +$5.21K ﹤0.01% 58
2017
Q3
Sell
-350
Closed -$8K 79
2017
Q2
$8K Buy
+350
New +$7.67K ﹤0.01% 103
2015
Q1
Sell
-52,317
Closed -$1.38M 80
2014
Q4
$1.38M Buy
+52,317
New +$1.15M 0.2% 20

Other funds holding PGEN

JBF Capital's PGEN Position: Q4 2020 in Review

JBF Capital sold out of Precigen (PGEN) in Q4 2020, closing a stake of 350 shares — an estimated $1K sold.

JBF Capital first reported a position in PGEN in Q4 2014 and held it in 5 quarters. The position peaked at $1.38M in Q4 2014. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

  • JBF Capital reported no remaining Precigen position as of Q4 2020 after selling out during the quarter.
  • JBF Capital sold 350 Precigen shares in Q4 2020, an estimated $1K.
  • JBF Capital first reported a position in Precigen in Q4 2014 and held it in 5 quarters.
  • JBF Capital's Precigen position peaked at $1.38M in Q4 2014.
  • 151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on JBF Capital's 13F filing for Q4 2020, filed 11 Feb 2021.